Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 362

Results For "UP"

8381 News Found

Mitsui Chemicals launches InnoCell cell Culture microplates with exceptional oxygen permeability
News | July 03, 2025

Mitsui Chemicals launches InnoCell cell Culture microplates with exceptional oxygen permeability

InnoCell is the brand name for Mitsui Chemicals’ cell culture products and services


INmune Bio reports core findings from Phase 2 trial in early Alzheimer’s disease
Clinical Trials | July 02, 2025

INmune Bio reports core findings from Phase 2 trial in early Alzheimer’s disease

Treatment with XPro was well-tolerated and safe, even in the high risk ApoE4+/+ patient group, and ARIA-E or ARIA-H was not observed in any patients


India exports US$ 4,961 million pharmaceutical during April–May 2025: Pharmexcil
Policy | July 02, 2025

India exports US$ 4,961 million pharmaceutical during April–May 2025: Pharmexcil

Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future


Glaukos receives EU MDR certification for iStent infinite
Medical Device | July 02, 2025

Glaukos receives EU MDR certification for iStent infinite

The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma


Moderna announces promising efficacy results from mRNA flu vaccine trial
Clinical Trials | July 01, 2025

Moderna announces promising efficacy results from mRNA flu vaccine trial

mRNA-1010 demonstrated superior relative vaccine efficacy


PerkinElmer appoints Payal Agrawaal as MD - India & South Asia
People | July 01, 2025

PerkinElmer appoints Payal Agrawaal as MD - India & South Asia

She will lead efforts to deepen regional market presence, foster innovation, and support scientific advancement across South Asia


AbbVie to acquire Capstan Therapeutics for $2.1 billion
Biotech | July 01, 2025

AbbVie to acquire Capstan Therapeutics for $2.1 billion

Capstan's lead asset, CPTX2309, is a targeted lipid nanoparticle (tLNP) that delivers an mRNA encoding an anti-CD19 chimeric antigen receptor (CAR) to CD8-expressing cytotoxic T cells in vivo


Pfizer strengthens AI collaboration with XtalPi to accelerate drug discovery
Digitisation | July 01, 2025

Pfizer strengthens AI collaboration with XtalPi to accelerate drug discovery

The collaboration aims to enhance the accuracy of physics-based methods with AI models for optimising small molecule medicine discovery and development


Briefs: Lyfius Pharma and Aurobindo Pharma
News | July 01, 2025

Briefs: Lyfius Pharma and Aurobindo Pharma

Lyfius Pharma restarts operations at Penicillin-G manufacturing facility


Indegene identified as leader in ISG's Provider Lens for life sciences digital services
News | July 01, 2025

Indegene identified as leader in ISG's Provider Lens for life sciences digital services

ISG acknowledged Indegene's strengths in implementing holistic creative workflows, interoperability via robust integration with tech ecosystems